NASHVILLE, TENNESSEE — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested.
Investigational MS Med Nearly Eliminates... - My MSAA Community
Investigational MS Med Nearly Eliminates Disease Activity on MRI
Written by
BettysMom
To view profiles and participate in discussions please or .
Read more about...
6 Replies
•
that is totally a dream come true!
Hope the Phase 3 trials are positive as well.
No evidence of increased infection risk! That could be a game changer.
This could be a game changer! Hope the next phase has great results as well!
Thank you
Thank you for posting this.
Not what you're looking for?
You may also like...
Blood Test for MS Activity Gets FDA Breakthrough Designation
detection of disease activity in adults aged 18-55 years with relapsing-remitting multiple...
MRI didn't show active disease
was some thinning of the myelin there was no active disease at this time. The symptom that led me...
Three Distinct MS Subtypes Identified
MDedge/neurology 09April 2024
https://www.mdedge.com/neurology/article/268641/multiple-scleros
DO MRI STUDIES ACCURATELY REFLECT YOUR DISEASE STATUS?
Characterizing Clinical and MRI Dissociation in Patients With Multiple Sclerosis published...
Is MRI of the brain enough for exploring MS?
the symptoms. Cat scan , mri of the brain and bloodwork unremarkable, though mri mentioned some...
Testing for MS and MRI differences
MS and Autoimmune Liver Disease
Autoimmune Diseases along with MS
Best word: \"MS\" or \"autoimmune disease\"?
